Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial

IMPORTANCE: Oxaliplatin added to fluorouracil plus leucovorin therapy for patients with colon cancer has been shown to provide significant but modest absolute benefit for disease-free survival. However, acute and chronic neurotoxic effects from this regimen underscore the need for markers that predi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Oncol
Glavni autori: Song, Nan, Pogue-Geile, Katherine L., Gavin, Patrick G., Yothers, Greg, Kim, S. Rim, Johnson, Nicole L., Lipchik, Corey, Allegra, Carmen J., Petrelli, Nicholas J., O’Connell, Michael J., Wolmark, Norman, Paik, Soonmyung
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065181/
https://ncbi.nlm.nih.gov/pubmed/27270348
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.2314
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items